Development of individual fitness score for conformity of prescriptions to the "Guidelines For Pharmacological Therapy of Schizophrenia"

• Main Authors: Ken Inada (Author), Kentaro Fukumoto (Author), Naomi Hasegawa (Author), Yuka Yasuda (Author), Hisashi Yamada (Author), Hikaru Hori (Author), Kayo Ichihashi (Author), Hitoshi Iida (Author), Kazutaka Ohi (Author), Hiroyuki Muraoka (Author), Fumitoshi Kodaka (Author), Kenta Ide (Author), Naoki Hashimoto (Author), Jun‐ichi Iga (Author), Kazuyoshi Ogasawara (Author), Kiyokazu Atake (Author), Yoshikazu Takaesu (Author), Tatsuya Nagasawa (Author), Hiroshi Komatsu (Author), Tsuyoshi Okada (Author), Ryuji Furihata (Author), Mikio Kido (Author), Saya Kikuchi (Author), Chika Kubota (Author), Manabu Makinodan (Author), Shinichiro Ochi (Author), Masahiro Takeshima (Author), Hirotaka Yamagata (Author), Junya Matsumoto (Author), Kenichiro Miura (Author), Masahide Usami (Author), Taishiro Kishimoto (Author), Toshiaki Onitsuka (Author), Eiichi Katsumoto (Author), Akitoyo Hishimoto (Author), Shusuke Numata (Author), Norio Yasui‐Furukori (Author), Koichiro Watanabe (Author), Ryota Hashimoto (Author)
• Format: Book
• Published: Wiley, 2022-12-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Abstract Aims The Guidelines for the Pharmacotherapy of Schizophrenia were established to improve the quality of medical care, and the EGUIDE project was conducted to train clinicians on guideline usage. A quality indicator (QI) was established to measure the prevalence of the guidelines, and a surv...